{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:10:27Z","timestamp":1793661027738,"version":"4.5.1"},"reference-count":274,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institutes of Arthritis and Musculoskeletal"},{"name":"Skin Diseases of the National Institutes of Health","award":["NIH R01 AR063184"],"award-info":[{"award-number":["NIH R01 AR063184"]}]},{"name":"Skin Diseases of the National Institutes of Health","award":["NIH R01 AR071552"],"award-info":[{"award-number":["NIH R01 AR071552"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.actbio.2019.01.060","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T22:51:05Z","timestamp":1548975065000},"page":"152-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair"],"prefix":"10.1016","volume":"93","author":[{"given":"Yuze","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaul","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyni","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b0005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2012.05.006","article-title":"Biomaterial delivery of morphogens to mimic the natural healing cascade in bone","volume":"64","author":"Mehta","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1586\/17434440.3.1.49","article-title":"Bone graft substitutes","volume":"3","author":"Laurencin","year":"2006","journal-title":"Expert Rev. Med. Devices"},{"issue":"5484","key":"10.1016\/j.actbio.2019.01.060_b0015","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.actbio.2019.01.060_b0020","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1302\/0301-620X.90B7.20498","article-title":"Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review","volume":"90","author":"AlBuhairan","year":"2008","journal-title":"J. Bone Joint Surg. British Volume"},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0025","first-page":"E2","article-title":"Infection prevention in total knee and total hip arthroplasties","volume":"37","author":"Kuper","year":"2008","journal-title":"Am. J. Orthopedics (Belle Mead, NJ)"},{"issue":"9","key":"10.1016\/j.actbio.2019.01.060_b0030","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ja.2011.58","article-title":"Recent advances in materials for extended-release antibiotic delivery system","volume":"64","author":"Gao","year":"2011","journal-title":"J. Antibiotics"},{"key":"10.1016\/j.actbio.2019.01.060_b0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biomaterials.2015.02.020","article-title":"Antimicrobial delivery systems for local infection prophylaxis in orthopedic-and trauma surgery","volume":"52","author":"ter Boo","year":"2015","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.actbio.2019.01.060_b0040","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/mabi.201500085","article-title":"Dendritic glycopolymer as drug delivery system for proteasome inhibitor bortezomib in a calcium phosphate bone cement: first steps toward a local therapy of osteolytic bone lesions","volume":"15","author":"Striegler","year":"2015","journal-title":"Macromol. Biosci."},{"issue":"13","key":"10.1016\/j.actbio.2019.01.060_b0045","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/adfm.200600361","article-title":"Biomimetic hydroxyapatite\u2013drug nanocrystals as potential bone substitutes with antitumor drug delivery properties","volume":"17","author":"Palazzo","year":"2007","journal-title":"Adv. Funct. Mater."},{"issue":"19","key":"10.1016\/j.actbio.2019.01.060_b0050","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"New Engl. J. Med."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday","volume":"126","author":"McClung","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.actbio.2019.01.060_b0060","series-title":"The Treatment of Postmenopausal Osteoporosis, Prevention and Treatment of Osteoporosis in the High-Risk Patient","first-page":"58","author":"Delmas","year":"2005"},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0065","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1359\/jbmr.091035","article-title":"Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density","volume":"25","author":"Bone","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.actbio.2019.01.060_b0070","article-title":"Local delivery of adenosine receptor agonists to promote bone regeneration and defect healing","author":"Lopez","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0075","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.actbio.2009.02.019","article-title":"Cationic liposome\u2013DNA complexes as gene delivery vectors: development and behaviour towards bone-like cells","volume":"5","author":"Oliveira","year":"2009","journal-title":"Acta Biomater."},{"issue":"21","key":"10.1016\/j.actbio.2019.01.060_b0080","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1016\/j.biomaterials.2011.03.041","article-title":"Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b0085","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.addr.2012.03.013","article-title":"Gene delivery to bone","volume":"64","author":"Evans","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0090","doi-asserted-by":"crossref","first-page":"288-+","DOI":"10.1038\/nm.3791","article-title":"Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy","volume":"21","author":"Liang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2019.01.060_b0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biomaterials.2016.02.018","article-title":"Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats","volume":"87","author":"Balmayor","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.01.060_b0100","doi-asserted-by":"crossref","first-page":"10376","DOI":"10.1038\/ncomms10376","article-title":"Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2019.01.060_b0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biomaterials.2017.06.001","article-title":"Controlled and sustained delivery of siRNA\/NPs from hydrogels expedites bone fracture healing","volume":"139","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0110","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s11095-017-2147-x","article-title":"Formulation delivery and stability of bone morphogenetic proteins for effective bone regeneration","volume":"34","author":"El Bialy","year":"2017","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0120","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.actbio.2013.09.042","article-title":"Therapeutic bioactive microcarriers: co-delivery of growth factors and stem cells for bone tissue engineering","volume":"10","author":"Perez","year":"2014","journal-title":"Acta Biomater."},{"issue":"24","key":"10.1016\/j.actbio.2019.01.060_b0125","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1016\/j.biomaterials.2010.04.053","article-title":"Toward delivery of multiple growth factors in tissue engineering","volume":"31","author":"Chen","year":"2010","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1586\/17434440.3.1.29","article-title":"Growth factor-delivery systems for tissue engineering: a materials perspective","volume":"3","author":"Vasita","year":"2006","journal-title":"Expert Rev. Med. Devices"},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b0135","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.addr.2012.01.016","article-title":"Strategies for controlled delivery of growth factors and cells for bone regeneration","volume":"64","author":"Vo","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2019.01.060_b0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.addr.2015.04.007","article-title":"Extracellular matrix-inspired growth factor delivery systems for bone regeneration","volume":"94","author":"Martino","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0145","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00264-007-0418-6","article-title":"A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE\u00ae Bone Graft)","volume":"31","author":"McKay","year":"2007","journal-title":"Int. Orthop."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0150","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00264-007-0424-8","article-title":"Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery","volume":"31","author":"Bishop","year":"2007","journal-title":"Int. Orthop."},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/ten.teb.2015.0357","article-title":"A review of the clinical side effects of bone morphogenetic protein-2","volume":"22","author":"James","year":"2016","journal-title":"Tissue Eng. Part B: Rev."},{"issue":"33","key":"10.1016\/j.actbio.2019.01.060_b0160","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1016\/j.biomaterials.2012.08.024","article-title":"Comparison of micro-vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: bone morphogenetic protein-2 and alkaline phosphatase","volume":"33","author":"Wang","year":"2012","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b0165","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.addr.2003.08.010","article-title":"Collagen sponges for bone regeneration with rhBMP-2","volume":"55","author":"Geiger","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2010.06.025","article-title":"Fibrin glue as a drug delivery system","volume":"148","author":"Spicer","year":"2010","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biomaterials.2010.08.074","article-title":"An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects","volume":"32","author":"Kolambkar","year":"2011","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.actbio.2019.01.060_b0180","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.biomaterials.2006.01.022","article-title":"Electrospun silk-BMP-2 scaffolds for bone tissue engineering","volume":"27","author":"Li","year":"2006","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2011.04.007","article-title":"Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine","volume":"155","author":"Prestwich","year":"2011","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0190","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.actbio.2013.09.039","article-title":"Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery","volume":"10","author":"Miller","year":"2014","journal-title":"Acta Biomater."},{"issue":"21","key":"10.1016\/j.actbio.2019.01.060_b0195","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.biomaterials.2009.03.024","article-title":"Incorporation of a sequential BMP-2\/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering","volume":"30","author":"Yilgor","year":"2009","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b0200","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.addr.2012.06.008","article-title":"Demineralized bone matrix in bone repair: history and use","volume":"64","author":"Gruskin","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.actbio.2019.01.060_b0205","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1016\/j.actbio.2013.04.029","article-title":"Hydrogels derived from demineralized and decellularized bone extracellular matrix","volume":"9","author":"Sawkins","year":"2013","journal-title":"Acta Biomater."},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b0210","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1039\/C6TB02730J","article-title":"Self-assembly of pifithrin-\u03b1-loaded layered double hydroxide\/chitosan nanohybrid composites as a drug delivery system for bone repair materials","volume":"5","author":"Chen","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2019.01.060_b0215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.msec.2017.02.112","article-title":"Biocompatible nanocomposite scaffolds based on copolymer-grafted chitosan for bone tissue engineering with drug delivery capability","volume":"75","author":"Saber-Samandari","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"37","key":"10.1016\/j.actbio.2019.01.060_b0220","doi-asserted-by":"crossref","first-page":"24463","DOI":"10.1021\/acsami.6b08180","article-title":"Silk\u2013hydroxyapatite nanoscale scaffolds with programmable growth factor delivery for bone repair","volume":"8","author":"Ding","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0225","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1021\/cm200733s","article-title":"Three-dimensional collagen\/alginate hybrid scaffolds functionalized with a drug delivery system (DDS) for bone tissue regeneration","volume":"24","author":"Lee","year":"2012","journal-title":"Chem. Mater."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2008.11.020","article-title":"Porous nano-HA\/collagen\/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2","volume":"134","author":"Niu","year":"2009","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0235","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.actbio.2008.04.002","article-title":"Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2","volume":"4","author":"Patel","year":"2008","journal-title":"Acta Biomater."},{"issue":"7","key":"10.1016\/j.actbio.2019.01.060_b0240","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/adma.201403354","article-title":"Natural-based nanocomposites for bone tissue engineering and regenerative medicine: a review","volume":"27","author":"Pina","year":"2015","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-3659(02)00181-5","article-title":"Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization","volume":"83","author":"Burdick","year":"2002","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0250","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"issue":"22","key":"10.1016\/j.actbio.2019.01.060_b0255","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.biomaterials.2008.04.031","article-title":"Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering","volume":"29","author":"Kempen","year":"2008","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2011.09.064","article-title":"Poly-\u0454-caprolactone based formulations for drug delivery and tissue engineering: a review","volume":"158","author":"Dash","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0265","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1098\/rsfs.2011.0121","article-title":"Mesoporous bioactive glasses: structure characteristics, drug\/growth factor delivery and bone regeneration application","volume":"2","author":"Wu","year":"2012","journal-title":"Interface Focus"},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0270","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2006.04.007","article-title":"Calcium phosphate cements as bone drug delivery systems: a review","volume":"113","author":"Ginebra","year":"2006","journal-title":"J. Control. Release"},{"issue":"13\u201314","key":"10.1016\/j.actbio.2019.01.060_b0275","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.drudis.2010.05.003","article-title":"Calcium phosphate biomaterials as bone drug delivery systems: a review","volume":"15","author":"Verron","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0280","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.actbio.2011.11.017","article-title":"Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review","volume":"8","author":"Bose","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.01.060_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2017.02.012","article-title":"Design of calcium phosphate ceramics for drug delivery applications in bone diseases: a review of the parameters affecting the loading and release of the therapeutic substance","volume":"252","author":"Parent","year":"2017","journal-title":"J. Control Release"},{"issue":"7","key":"10.1016\/j.actbio.2019.01.060_b0290","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.actbio.2011.03.019","article-title":"Nanoscale hydroxyapatite particles for bone tissue engineering","volume":"7","author":"Zhou","year":"2011","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.actbio.2019.01.060_b0295","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1016\/j.actbio.2013.07.009","article-title":"SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo","volume":"9","author":"Fielding","year":"2013","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0300","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.joms.2011.02.133","article-title":"Current trends in mesenchymal stem cell application in bone augmentation: a review of the literature","volume":"70","author":"Khojasteh","year":"2012","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"8","key":"10.1016\/j.actbio.2019.01.060_b0305","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1073\/pnas.0905444107","article-title":"Human stem cell delivery for treatment of large segmental bone defects","volume":"107","author":"Dupont","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/stem.1559","article-title":"Concise review: Bridging the gap: Bone regeneration using skeletal stem cell-based strategies\u2014Where are we now?","volume":"32","author":"Dawson","year":"2014","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0315","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1208\/s12249-010-9526-5","article-title":"Injectable lipid emulsions\u2014advancements, opportunities and challenges","volume":"11","author":"Hippalgaonkar","year":"2010","journal-title":"Aaps Pharmscitech"},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0320","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.actbio.2009.12.014","article-title":"Polymeric micelle-templated synthesis of hydroxyapatite hollow nanoparticles for a drug delivery system","volume":"6","author":"Ye","year":"2010","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.actbio.2019.01.060_b0325","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.addr.2008.03.008","article-title":"Micelles and nanoparticles for ultrasonic drug and gene delivery","volume":"60","author":"Husseini","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.actbio.2019.01.060_b0330","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"issue":"23","key":"10.1016\/j.actbio.2019.01.060_b0335","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1016\/j.biomaterials.2013.03.067","article-title":"The stability of BMP loaded polyelectrolyte multilayer coatings on titanium","volume":"34","author":"Guillot","year":"2013","journal-title":"Biomaterials"},{"issue":"191","key":"10.1016\/j.actbio.2019.01.060_b0340","doi-asserted-by":"crossref","first-page":"191ra83","DOI":"10.1126\/scitranslmed.3005576","article-title":"Surface-mediated bone tissue morphogenesis from tunable nanolayered implant coatings","volume":"5","author":"Shah","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actbio.2019.01.060_b0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2014.05.053","article-title":"Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation","volume":"191","author":"Holloway","year":"2014","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.actbio.2019.01.060_b0350","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1016\/j.biomaterials.2010.02.052","article-title":"Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects","volume":"31","author":"Wang","year":"2010","journal-title":"Biomaterials"},{"issue":"43","key":"10.1016\/j.actbio.2019.01.060_b0355","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1098\/rsif.2009.0379","article-title":"Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds","volume":"7","author":"Mourino","year":"2010","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.actbio.2019.01.060_b0360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2015.03.013","article-title":"Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair","volume":"94","author":"Agarwal","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1963","key":"10.1016\/j.actbio.2019.01.060_b0365","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1098\/rsta.2011.0258","article-title":"Structure and functionalization of mesoporous bioceramics for bone tissue regeneration and local drug delivery","volume":"370","author":"Vallet-Regi","year":"2012","journal-title":"Philos. T. R. Soc. A"},{"issue":"10","key":"10.1016\/j.actbio.2019.01.060_b0370","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1517\/17425247.2013.808183","article-title":"Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering","volume":"10","author":"Mourino","year":"2013","journal-title":"Expert Opin. Drug Del."},{"key":"10.1016\/j.actbio.2019.01.060_b0375","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.11.021","article-title":"Development of collagen\u2013hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering","volume":"198","author":"Quinlan","year":"2015","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0380","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10439-016-1678-3","article-title":"3D printing of calcium phosphate ceramics for bone tissue engineering and drug delivery","volume":"45","author":"Trombetta","year":"2017","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.actbio.2019.01.060_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2018.08.013","article-title":"A critical review of multifunctional titanium surfaces: new frontiers for improving osseointegration and host response, avoiding bacteria contamination","volume":"79","author":"Spriano","year":"2018","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0390","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.actbio.2007.09.011","article-title":"Novel fabrication techniques to produce microspheres by thermally induced phase separation for tissue engineering and drug delivery","volume":"4","author":"Blaker","year":"2008","journal-title":"Acta Biomater."},{"issue":"33","key":"10.1016\/j.actbio.2019.01.060_b0395","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1002\/chem.201402244","article-title":"Mechanical downsizing of a gadolinium (III)-based metal-organic framework for anticancer drug delivery","volume":"20","author":"Kundu","year":"2014","journal-title":"Chem.\u2013A Eur. J."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0400","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.biomaterials.2009.10.059","article-title":"The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation","volume":"31","author":"Kanczler","year":"2010","journal-title":"Biomaterials"},{"issue":"14","key":"10.1016\/j.actbio.2019.01.060_b0405","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/0142-9612(96)87284-X","article-title":"Novel approach to fabricate porous sponges of poly (D, L-lactic-co-glycolic acid) without the use of organic solvents","volume":"17","author":"Mooney","year":"1996","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0410","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.actbio.2011.12.020","article-title":"Hot melt poly-\u03b5-caprolactone\/poloxamine implantable matrices for sustained delivery of ciprofloxacin","volume":"8","author":"Puga","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.01.060_b0415","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2015.09.050","article-title":"Chemically modified RNA activated matrices enhance bone regeneration","volume":"218","author":"Elangovan","year":"2015","journal-title":"J Control Release"},{"issue":"36","key":"10.1016\/j.actbio.2019.01.060_b0420","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1016\/j.biomaterials.2010.08.035","article-title":"Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections","volume":"31","author":"Kazemzadeh-Narbat","year":"2010","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0425","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2011.06.027","article-title":"Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels","volume":"154","author":"Jeon","year":"2011","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.actbio.2019.01.060_b0430","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/j.actbio.2011.04.018","article-title":"Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2","volume":"7","author":"Xu","year":"2011","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0435","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/ten.tea.2009.0390","article-title":"Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2","volume":"16","author":"Yang","year":"2010","journal-title":"Tissue Eng. Part A"},{"issue":"17","key":"10.1016\/j.actbio.2019.01.060_b0440","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1016\/j.biomaterials.2007.02.023","article-title":"Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold","volume":"28","author":"Jeon","year":"2007","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b0445","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1021\/bm101041f","article-title":"Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells","volume":"11","author":"Sangaj","year":"2010","journal-title":"Biomacromolecules"},{"issue":"16","key":"10.1016\/j.actbio.2019.01.060_b0450","doi-asserted-by":"crossref","first-page":"7702","DOI":"10.1021\/acs.chemrev.8b00253","article-title":"Achieving controlled biomolecule-biomaterial conjugation","volume":"118","author":"Spicer","year":"2018","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0455","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.actbio.2011.10.019","article-title":"Surface immobilization of bone morphogenetic protein 2 via a self-assembled monolayer formation induces cell differentiation","volume":"8","author":"Pohl","year":"2012","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.actbio.2019.01.060_b0460","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1016\/j.actbio.2010.06.009","article-title":"Peri-implant reactivity and osteoinductive potential of immobilized rhBMP-2 on titanium carriers","volume":"6","author":"Chatzinikolaidou","year":"2010","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.actbio.2019.01.060_b0465","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1089\/ten.tea.2010.0132","article-title":"Chemically-conjugated bone morphogenetic protein-2 on three-dimensional polycaprolactone scaffolds stimulates osteogenic activity in bone marrow stromal cells","volume":"16","author":"Zhang","year":"2010","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.actbio.2019.01.060_b0470","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.12.031","article-title":"Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel","volume":"223","author":"Barati","year":"2016","journal-title":"J. Control. Release"},{"issue":"30","key":"10.1016\/j.actbio.2019.01.060_b0475","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.1016\/j.biomaterials.2013.06.019","article-title":"BMP-2 peptide-functionalized nanopatterned substrates for enhanced osteogenic differentiation of human mesenchymal stem cells","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0480","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1021\/bm900203w","article-title":"Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration","volume":"10","author":"Shi","year":"2009","journal-title":"Biomacromolecules"},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0485","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1089\/ten.2006.0209","article-title":"Heterobifunctional poly (Ethylene Glycol)\u2013tethered bone morphogenetic protein-2\u2013stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis","volume":"13","author":"Liu","year":"2007","journal-title":"Tissue Eng."},{"issue":"9","key":"10.1016\/j.actbio.2019.01.060_b0490","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/jbm.a.36430","article-title":"A canine in vitro model for evaluation of marrow-derived mesenchymal stromal cell-based bone scaffolds","volume":"106","author":"Gharat","year":"2018","journal-title":"J. Biomed. Mater. Res."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0495","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejpb.2004.03.004","article-title":"Localized delivery of growth factors for bone repair","volume":"58","author":"Luginbuehl","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0500","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/acs.biomac.6b01407","article-title":"Site-directed immobilization of BMP-2: two approaches for the production of innovative osteoinductive scaffolds","volume":"18","author":"Tabisz","year":"2017","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0505","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.biomaterials.2008.10.040","article-title":"Directional BMP-2 for functionalization of titanium surfaces","volume":"30","author":"Kashiwagi","year":"2009","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0510","first-page":"155","article-title":"Drug delivery using composite scaffolds in the context of bone tissue engineering","volume":"10","author":"Romagnoli","year":"2013","journal-title":"Clin. Cases Miner. Bone Metab."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0515","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jconrel.2006.11.016","article-title":"Novel glycidyl methacrylated dextran (Dex-GMA)\/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics","volume":"118","author":"Chen","year":"2007","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0520","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1021\/acsami.6b12325","article-title":"Strontium-doped amorphous calcium phosphate porous microspheres synthesized through a microwave-hydrothermal method using fructose 1, 6-bisphosphate as an organic phosphorus source: application in drug delivery and enhanced bone regeneration","volume":"9","author":"Yu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"8","key":"10.1016\/j.actbio.2019.01.060_b0525","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.actbio.2011.04.008","article-title":"Direct deposited porous scaffolds of calcium phosphate cement with alginate for drug delivery and bone tissue engineering","volume":"7","author":"Lee","year":"2011","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0530","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1073\/pnas.1321717111","article-title":"Calcium phosphate-bearing matrices induce osteogenic differentiation of stem cells through adenosine signaling","volume":"111","author":"Shih","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.actbio.2019.01.060_b0535","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/mabi.201100289","article-title":"Mineralized synthetic matrices as an instructive microenvironment for osteogenic differentiation of human mesenchymal stem cells","volume":"12","author":"Phadke","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.actbio.2019.01.060_b0540","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.actbio.2018.06.035","article-title":"Effect of age on biomaterial-mediated in situ bone tissue regeneration","volume":"78","author":"Liu","year":"2018","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0545","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s13346-015-0242-2","article-title":"In vivo comparison of biomineralized scaffold-directed osteogenic differentiation of human embryonic and mesenchymal stem cells","volume":"6","author":"Wen","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b0550","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1016\/j.actbio.2014.08.010","article-title":"Mineralized gelatin methacrylate-based matrices induce osteogenic differentiation of human induced pluripotent stem cells","volume":"10","author":"Kang","year":"2014","journal-title":"Acta Biomater."},{"issue":"7","key":"10.1016\/j.actbio.2019.01.060_b0555","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.actbio.2009.03.011","article-title":"Intrinsic porosity of calcium phosphate cements and its significance for drug delivery and tissue engineering applications","volume":"5","author":"Espanol","year":"2009","journal-title":"Acta Biomater."},{"issue":"45","key":"10.1016\/j.actbio.2019.01.060_b0560","doi-asserted-by":"crossref","first-page":"25480","DOI":"10.1039\/C8RA03943G","article-title":"Preparation of porous calcium phosphate microspheres with phosphate-containing molecules at room temperature for drug delivery and osteogenic differentiation","volume":"8","author":"Liu","year":"2018","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0565","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/jop.12464","article-title":"A biphasic calcium phosphate coating for potential drug delivery affects early osseointegration of titanium implants","volume":"46","author":"Kammerer","year":"2017","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.actbio.2019.01.060_b0570","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1089\/ten.tea.2017.0297","article-title":"Mineralized biomaterials mediated repair of bone defects through endogenous cells","volume":"24","author":"Gonzalez Diaz","year":"2018","journal-title":"Tissue Eng. A."},{"issue":"21","key":"10.1016\/j.actbio.2019.01.060_b0575","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1073\/pnas.1702576114","article-title":"In, vivo engineering of bone tissues with hematopoietic functions and mixed chimerism","volume":"114","author":"Shih","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.actbio.2019.01.060_b0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2015.03.017","article-title":"Synthetic bone mimetic matrix-mediated in situ bone tissue formation through host cell recruitment","volume":"19","author":"Shih","year":"2015","journal-title":"Acta Biomater."},{"issue":"8","key":"10.1016\/j.actbio.2019.01.060_b0585","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1016\/j.actbio.2010.02.026","article-title":"The effect of BMP-2 on micro-and macroscale osteointegration of biphasic calcium phosphate scaffolds with multiscale porosity","volume":"6","author":"Levengood","year":"2010","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0590","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2011.03.010","article-title":"Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres","volume":"153","author":"Son","year":"2011","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.actbio.2019.01.060_b0595","doi-asserted-by":"crossref","first-page":"1606134","DOI":"10.1002\/adma.201606134","article-title":"Metal-organic framework (MOF)-based drug\/cargo delivery and cancer therapy","volume":"29","author":"Wu","year":"2017","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0600","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1039\/C6BM00903D","article-title":"Calcium phosphate bone cement\/mesoporous bioactive glass composites for controlled growth factor delivery","volume":"5","author":"Schumacher","year":"2017","journal-title":"Biomater Sci"},{"issue":"9","key":"10.1016\/j.actbio.2019.01.060_b0605","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.actbio.2012.06.003","article-title":"Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules","volume":"8","author":"Bhattacharyya","year":"2012","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.actbio.2019.01.060_b0610","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.addr.2008.03.012","article-title":"Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers","volume":"60","author":"Slowing","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0615","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.actbio.2007.11.009","article-title":"L-Trp adsorption into silica mesoporous materials to promote bone formation","volume":"4","author":"Balas","year":"2008","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.01.060_b0620","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.actbio.2017.04.012","article-title":"Copper-containing mesoporous bioactive glass nanoparticles as multifunctional agent for bone regeneration","volume":"55","author":"Bari","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.01.060_b0625","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.actbio.2017.07.021","article-title":"Intracellular co-delivery of Sr ion and phenamil drug through mesoporous bioglass nanocarriers synergizes BMP signaling and tissue mineralization","volume":"60","author":"Lee","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.01.060_b0630","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.actbio.2016.06.033","article-title":"Bioactive glass-based materials with hierarchical porosity for medical applications: review of recent advances","volume":"42","author":"Baino","year":"2016","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0635","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J."},{"key":"10.1016\/j.actbio.2019.01.060_b0640","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.actbio.2018.05.054","article-title":"Sustained delivery of siRNA\/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing","volume":"76","author":"Pinese","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.01.060_b0645","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.actbio.2014.12.028","article-title":"Therapeutic-designed electrospun bone scaffolds: mesoporous bioactive nanocarriers in hollow fiber composites to sequentially deliver dual growth factors","volume":"16","author":"Kang","year":"2015","journal-title":"Acta Biomater."},{"issue":"16","key":"10.1016\/j.actbio.2019.01.060_b0650","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800361","article-title":"3D printing nanoscale bioactive glass scaffolds enhance osteoblast migration and extramembranous osteogenesis through stimulating immunomodulation","volume":"7","author":"Zhao","year":"2018","journal-title":"Adv. Healthcare Mater."},{"issue":"43","key":"10.1016\/j.actbio.2019.01.060_b0655","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1039\/C4TB01063A","article-title":"3D-printed magnetic Fe 3 O 4\/MBG\/PCL composite scaffolds with multifunctionality of bone regeneration, local anticancer drug delivery and hyperthermia","volume":"2","author":"Zhang","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2019.01.060_b0660","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.actbio.2015.08.036","article-title":"3D plotting of growth factor loaded calcium phosphate cement scaffolds","volume":"27","author":"Akkineni","year":"2015","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.actbio.2019.01.060_b0665","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/adfm.200901759","article-title":"Simultaneous immobilization of bioactives during 3D powder printing of bioceramic drug-release matrices","volume":"20","author":"Vorndran","year":"2010","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2019.01.060_b0670","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.actbio.2018.09.003","article-title":"Osteogenesis by foamed and 3D-printed nanostructured calcium phosphate scaffolds: effect of pore architecture","volume":"79","author":"Barba","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.01.060_b0675","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.actbio.2018.08.026","article-title":"3D-printed bioceramic scaffolds: from bone tissue engineering to tumor therapy","volume":"79","author":"Ma","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.01.060_b0680","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.copbio.2016.02.029","article-title":"Local and targeted drug delivery for bone regeneration","volume":"40","author":"Newman","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"issue":"47","key":"10.1016\/j.actbio.2019.01.060_b0685","doi-asserted-by":"crossref","first-page":"14444","DOI":"10.1073\/pnas.1516247112","article-title":"Progress in material design for biomedical applications","volume":"112","author":"Tibbitt","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.actbio.2019.01.060_b0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.10.049","article-title":"Local pulsatile PTH delivery regenerates bone defects via enhanced bone remodeling in a cell-free scaffold","volume":"114","author":"Dang","year":"2017","journal-title":"Biomaterials"},{"issue":"22","key":"10.1016\/j.actbio.2019.01.060_b0695","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/j.biomaterials.2011.03.063","article-title":"Effects of protein dose and delivery system on BMP-mediated bone regeneration","volume":"32","author":"Boerckel","year":"2011","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0700","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425241003602259","article-title":"Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems","volume":"7","author":"Fu","year":"2010","journal-title":"Expert Opin. Drug Del."},{"key":"10.1016\/j.actbio.2019.01.060_b0705","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/ncomms2271","article-title":"Moving from static to dynamic complexity in hydrogel design","volume":"3","author":"Burdick","year":"2012","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0710","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.actbio.2009.10.043","article-title":"Loading and release of doxycycline hyclate from strontium-substituted calcium phosphate cement","volume":"6","author":"Alkhraisat","year":"2010","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.actbio.2019.01.060_b0715","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/nmat3758","article-title":"Macroscale delivery systems for molecular and cellular payloads","volume":"12","author":"Kearney","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.actbio.2019.01.060_b0720","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.biomaterials.2015.11.018","article-title":"Poly(ethylene glycol) hydrogels with cell cleavable groups for autonomous cell delivery","volume":"77","author":"Kar","year":"2016","journal-title":"Biomaterials"},{"issue":"20","key":"10.1016\/j.actbio.2019.01.060_b0725","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1039\/C5TB00468C","article-title":"Thermo\/redox\/pH-triple sensitive poly(N-isopropylacrylamide-co-acrylic acid) nanogels for anticancer drug delivery","volume":"3","author":"Zhan","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2019.01.060_b0730","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.actbio.2015.05.010","article-title":"Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells","volume":"23","author":"Zhao","year":"2015","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0735","doi-asserted-by":"crossref","first-page":"1800259","DOI":"10.1002\/mabi.201800259","article-title":"Stimuli-responsive supramolecular hydrogels and their applications in regenerative medicine","volume":"19","author":"Hoque","year":"2018","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.actbio.2019.01.060_b0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0929867325666181008144436","article-title":"Phenylboronic acid-polymers for biomedical applications","volume":"26","author":"Ryu","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"48","key":"10.1016\/j.actbio.2019.01.060_b0745","doi-asserted-by":"crossref","first-page":"17227","DOI":"10.1021\/ja1069932","article-title":"Self-cross-linked polymer nanogels: a versatile nanoscopic drug delivery platform","volume":"132","author":"Ryu","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.actbio.2019.01.060_b0750","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.biomaterials.2008.12.023","article-title":"Bone healing induced by local delivery of an engineered parathyroid hormone prodrug","volume":"30","author":"Arrighi","year":"2009","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0755","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nbt818","article-title":"Repair of bone defects using synthetic mimetics of collagenous extracellular matrices","volume":"21","author":"Lutolf","year":"2003","journal-title":"Nat. Biotech."},{"issue":"30","key":"10.1016\/j.actbio.2019.01.060_b0760","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1016\/j.biomaterials.2010.06.061","article-title":"Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2","volume":"31","author":"Patterson","year":"2010","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0765","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/adhm.201400695","article-title":"Development of a cellularly degradable PEG hydrogel to promote articular cartilage extracellular matrix deposition","volume":"4","author":"Sridhar","year":"2015","journal-title":"Adv. Healthcare Mater."},{"issue":"21","key":"10.1016\/j.actbio.2019.01.060_b0770","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1016\/j.biomaterials.2014.03.055","article-title":"Bone regeneration using an alpha 2 beta 1 integrin-specific hydrogel as a BMP-2 delivery vehicle","volume":"35","author":"Shekaran","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.01.060_b0775","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.biomaterials.2018.06.039","article-title":"Near-infrared light-triggered drug delivery system based on black phosphorus for in vivo bone regeneration","volume":"179","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0780","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7150\/thno.11389","article-title":"Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound\/magnetic resonance imaging of stem cells","volume":"5","author":"Kempen","year":"2015","journal-title":"Theranostics"},{"issue":"390","key":"10.1016\/j.actbio.2019.01.060_b0785","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3128","article-title":"In situ bone tissue engineering via ultrasound-mediated gene delivery to endogenous progenitor cells in mini-pigs","volume":"9","author":"Bez","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.actbio.2019.01.060_b0790","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1021\/acsnano.7b03197","article-title":"Targeting osteocytes to attenuate early breast cancer bone metastasis by theranostic upconversion nanoparticles with responsive plumbagin release","volume":"11","author":"Qiao","year":"2017","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0795","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/jacs.5b12357","article-title":"Photocleavable hydrogel-coated upconverting nanoparticles: a multifunctional theranostic platform for NIR imaging and on-demand macromolecular delivery","volume":"138","author":"Jalani","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actbio.2019.01.060_b0800","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2018.01.021","article-title":"Stimuli-responsive nanocarriers for delivery of bone therapeutics\u2013Barriers and progresses","volume":"273","author":"Lavrador","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.01.060_b0805","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.actbio.2017.04.002","article-title":"Bio-orthogonal conjugation and enzymatically triggered release of proteins within multi-layered hydrogels","volume":"56","author":"Guo","year":"2017","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0810","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2017.87","article-title":"Photoresponsive biomaterials for targeted drug delivery and 4D cell culture","volume":"3","author":"Ruskowitz","year":"2018","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.actbio.2019.01.060_b0815","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.actbio.2018.08.019","article-title":"Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration","volume":"79","author":"Son","year":"2018","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0820","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrrheum.2014.164","article-title":"Fracture healing: mechanisms and interventions","volume":"11","author":"Einhorn","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0825","doi-asserted-by":"crossref","first-page":"1700821","DOI":"10.1002\/advs.201700821","article-title":"Self-stabilized hyaluronate nanogel for intracellular codelivery of doxorubicin and cisplatin to osteosarcoma","volume":"5","author":"Zhang","year":"2018","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.actbio.2019.01.060_b0830","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.biomaterials.2014.10.015","article-title":"Controlled dual delivery of BMP-2 and dexamethasone by nanoparticle-embedded electrospun nanofibers for the efficient repair of critical-sized rat calvarial defect","volume":"37","author":"Li","year":"2015","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0835","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.actbio.2014.01.016","article-title":"A collagen\u2013hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates","volume":"10","author":"Murphy","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2019.01.060_b0840","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.biomaterials.2018.01.006","article-title":"Dual non-viral gene delivery from microparticles within 3D high-density stem cell constructs for enhanced bone tissue engineering","volume":"161","author":"McMillan","year":"2018","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0845","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bone.2008.06.019","article-title":"Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model","volume":"43","author":"Patel","year":"2008","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0850","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.arthro.2011.10.018","article-title":"Platelet-rich plasma: a milieu of bioactive factors","volume":"28","author":"Boswell","year":"2012","journal-title":"Arthroscopy: J. Arthros. Related Surg."},{"issue":"29","key":"10.1016\/j.actbio.2019.01.060_b0855","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.biomaterials.2008.06.014","article-title":"The effect of platelet-rich plasma on healing in critical-size long-bone defects","volume":"29","author":"Kasten","year":"2008","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0860","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00264-016-3342-9","article-title":"Platelet-rich plasma for the treatment of bone defects: from pre-clinical rational to evidence in the clinical practice. A systematic review","volume":"41","author":"Roffi","year":"2017","journal-title":"Int. Orthop."},{"issue":"14","key":"10.1016\/j.actbio.2019.01.060_b0865","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.biomaterials.2009.01.031","article-title":"Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration","volume":"30","author":"Kempen","year":"2009","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b0870","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1021\/am501714k","article-title":"Hydrogel micropattern-incorporated fibrous scaffolds capable of sequential growth factor delivery for enhanced osteogenesis of hMSCs","volume":"6","author":"Lee","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"31","key":"10.1016\/j.actbio.2019.01.060_b0875","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2008.07.017","article-title":"Sequential growth factor delivery from complexed microspheres for bone tissue engineering","volume":"29","author":"Basmanav","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.01.060_b0880","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biomaterials.2014.10.017","article-title":"Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds","volume":"37","author":"Spiller","year":"2015","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0885","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/mz300585q","article-title":"Bioorthogonal click chemistry: an indispensable tool to create multifaceted cell culture scaffolds","volume":"2","author":"Azagarsamy","year":"2013","journal-title":"ACS Macro Lett."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b0890","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.10.001","article-title":"Bone targeting for the treatment of osteoporosis","volume":"161","author":"Luhmann","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.actbio.2019.01.060_b0895","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2015.10.005","article-title":"Targeted delivery to bone and mineral deposits using bisphosphonate ligands","volume":"99","author":"Cole","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b0900","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.actbio.2019.01.060_b0905","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1369-7021(05)71033-6","article-title":"Targeted for drug delivery","volume":"8","author":"Fahmy","year":"2005","journal-title":"Mater. Today"},{"key":"10.1016\/j.actbio.2019.01.060_b0910","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2017.11.009","article-title":"Drug delivery systems functionalized with bone mineral seeking agents for bone targeted therapeutics","volume":"269","author":"Rotman","year":"2018","journal-title":"J. Control Release"},{"key":"10.1016\/j.actbio.2019.01.060_b0915","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2016.01.033","article-title":"Importance of dual delivery systems for bone tissue engineering","volume":"225","author":"Farokhi","year":"2016","journal-title":"J. Control Release"},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0920","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1039\/B512310K","article-title":"'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents","volume":"36","author":"Zhang","year":"2007","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0925","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1021\/ja0759949","article-title":"NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model","volume":"130","author":"Mukherjee","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0930","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S8756-3282(98)00120-3","article-title":"Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: structure-activity relationships","volume":"23","author":"van Beek","year":"1998","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0935","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bone.2011.03.774","article-title":"The relationship between the chemistry and biological activity of the bisphosphonates","volume":"49","author":"Ebetino","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.actbio.2019.01.060_b0940","series-title":"Bifunctional Bisphosphonates for Delivering Biomolecules to Bone","author":"Yewle","year":"2012"},{"issue":"Suppl 2","key":"10.1016\/j.actbio.2019.01.060_b0945","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1007\/PL00004164","article-title":"Bisphosphonates: pharmacology, mechanisms of action and clinical uses","volume":"9","author":"Russell","year":"1999","journal-title":"Osteoporosis Int.: J. Established Result Cooperation Between the Eur. Found. Osteoporosis Nat. Osteoporosis Found. USA"},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b0950","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/8756-3282(96)00182-2","article-title":"Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones","volume":"19","author":"Masarachia","year":"1996","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b0955","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b0960","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jbm.b.31500","article-title":"Differences between bisphosphonates in binding affinities for hydroxyapatite","volume":"92B","author":"Lawson","year":"2010","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0965","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/ml5004603","article-title":"Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters","volume":"6","author":"Puljula","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.actbio.2019.01.060_b0970","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejmech.2014.02.054","article-title":"Bisphosphonate prodrugs: synthesis and biological evaluation in HuH7 hepatocarcinoma cells","volume":"77","author":"Monteil","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b0975","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/adhm.201300465","article-title":"Osteotropic therapy via targeted layer-by-layer nanoparticles","volume":"3","author":"Morton","year":"2014","journal-title":"Adv. Healthcare Mater."},{"issue":"10","key":"10.1016\/j.actbio.2019.01.060_b0980","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.oraloncology.2012.03.028","article-title":"Bisphosphonate-related osteonecrosis of the jaws \u2013 a review","volume":"48","author":"Kuhl","year":"2012","journal-title":"Oral. Oncol."},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b0985","first-page":"324","article-title":"Bisphosphonates for treatment of osteoporosis Expected benefits, potential harms, and drug holidays","volume":"60","author":"Brown","year":"2014","journal-title":"Can. Fam. Physician"},{"issue":"32","key":"10.1016\/j.actbio.2019.01.060_b0990","doi-asserted-by":"crossref","first-page":"E4601","DOI":"10.1073\/pnas.1603316113","article-title":"Pamidronate functionalized nanoconjugates for targeted therapy of focal skeletal malignant osteolysis","volume":"113","author":"Yin","year":"2016","journal-title":"PNAS"},{"issue":"123","key":"10.1016\/j.actbio.2019.01.060_b0995","doi-asserted-by":"crossref","first-page":"20160462","DOI":"10.1098\/rsif.2016.0462","article-title":"The role of amino acids in hydroxyapatite mineralization","volume":"13","author":"Tavafoghi","year":"2016","journal-title":"J. R. Soc. Interface"},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-008-0004-z","article-title":"Selective drug delivery to bone using acidic oligopeptides","volume":"27","author":"Ishizaki","year":"2009","journal-title":"J. Bone Miner. Metab."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b1005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ijpharm.2014.08.067","article-title":"Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications","volume":"475","author":"Jiang","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b1010","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1359\/jbmr.2000.15.5.936","article-title":"Selective drug delivery system to bone: small peptide (Asp)6 conjugation","volume":"15","author":"Kasugai","year":"2000","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.actbio.2019.01.060_b1015","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1021\/ma971629y","article-title":"Relationships between structure and properties of poly(aspartic acid)s","volume":"31","author":"Nakato","year":"1998","journal-title":"Macromolecules"},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b1020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/10611860108997922","article-title":"Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential","volume":"9","author":"Sekido","year":"2001","journal-title":"J. Drug Target."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b1025","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1021\/acsnano.5b07828","article-title":"Osteoblast-targeting-peptide modified nanoparticle for siRNA\/microRNA delivery","volume":"10","author":"Sun","year":"2016","journal-title":"ACS Nano"},{"issue":"36","key":"10.1016\/j.actbio.2019.01.060_b1030","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1016\/j.biomaterials.2010.08.064","article-title":"Phosphorylation-dependent mineral-type specificity for apatite-binding peptide sequences","volume":"31","author":"Addison","year":"2010","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.actbio.2019.01.060_b1035","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.biomaterials.2008.11.008","article-title":"The adsorption of preferential binding peptides to apatite-based materials","volume":"30","author":"Segvich","year":"2009","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b1040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b1045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02408616","article-title":"Tetracycline labeling of bone in vivo","volume":"30","author":"Tam","year":"1980","journal-title":"Calcified Tissue Int."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b1050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jcis.2010.04.081","article-title":"Studies on the sorption of tetracycline onto clays and marine sediment from seawater","volume":"349","author":"Wang","year":"2010","journal-title":"J. Colloid Interface Sci."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b1055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ab.2011.05.011","article-title":"Near-infrared-labeled tetracycline derivative is an effective marker of bone deposition in mice","volume":"416","author":"Kovar","year":"2011","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b1060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bmcl.2008.12.051","article-title":"Bone, selective effect of an estradiol conjugate with a novel tetracycline-derived bone-targeting agent","volume":"19","author":"Neale","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"126","key":"10.1016\/j.actbio.2019.01.060_b1065","first-page":"128","article-title":"A restorative challenge, tetracycline-stained teeth","volume":"34","author":"Cutbirth","year":"2015","journal-title":"Dent. Today"},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b1070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF00305526","article-title":"Comparison of bone formation rates measured by radiocalcium kinetics and double-tetracycline labeling in maintenance dialysis patients","volume":"54","author":"Cochran","year":"1994","journal-title":"Calcified Tissue Int."},{"issue":"47","key":"10.1016\/j.actbio.2019.01.060_b1075","doi-asserted-by":"crossref","first-page":"16477","DOI":"10.1021\/ja054905u","article-title":"A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting","volume":"127","author":"Kub\u00ed\u010dek","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.actbio.2019.01.060_b1080","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/jps.20186","article-title":"A di(bisphosphonic acid) for protein coupling and targeting to bone","volume":"93","author":"Bansal","year":"2004","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b1085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1039\/C7BM00930E","article-title":"Bone-targeting poly(ethylene sodium phosphate)","volume":"6","author":"Iwasaki","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.actbio.2019.01.060_b1090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bone.2016.08.002","article-title":"Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastases","volume":"91","author":"Lange","year":"2016","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b1095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2007.06.003","article-title":"Design of surface-modified poly(d, l-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone","volume":"122","author":"Choi","year":"2007","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b1100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jconrel.2011.11.020","article-title":"Bone, metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel","volume":"158","author":"Ramanlal Chaudhari","year":"2012","journal-title":"J. Control. Release"},{"issue":"19","key":"10.1016\/j.actbio.2019.01.060_b1105","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1002\/adfm.201102357","article-title":"Targeting efficiency and biodistribution of zoledronate conjugated docetaxel loaded pegylated PBCA nanoparticles for bone metastasis","volume":"22","author":"Chaudhari","year":"2012","journal-title":"Adv. Funct. Mater."},{"issue":"28","key":"10.1016\/j.actbio.2019.01.060_b1110","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.1073\/pnas.1401337111","article-title":"Engineered nanomedicine for myeloma and bone microenvironment targeting","volume":"111","author":"Swami","year":"2014","journal-title":"PNAS"},{"issue":"29","key":"10.1016\/j.actbio.2019.01.060_b1115","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1016\/j.biomaterials.2012.06.026","article-title":"Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer","volume":"33","author":"Thamake","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.01.060_b1120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2018.08.033","article-title":"Multifunctional melanin-like nanoparticles for bone-targeted chemo-photothermal therapy of malignant bone tumors and osteolysis","volume":"183","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.actbio.2019.01.060_b1125","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/adma.201202881","article-title":"Modular \u2018click-in-emulsion\u2019 bone-targeted nanogels","volume":"25","author":"Heller","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2019.01.060_b1130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.actbio.2018.09.022","article-title":"Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma","volume":"80","author":"Gu","year":"2018","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.actbio.2019.01.060_b1135","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/j.actbio.2014.07.015","article-title":"Aspartic acid-based modified PLGA\u2013PEG nanoparticles for bone targeting: in vitro and in vivo evaluation","volume":"10","author":"Fu","year":"2014","journal-title":"Acta Biomater."},{"issue":"29","key":"10.1016\/j.actbio.2019.01.060_b1140","doi-asserted-by":"crossref","first-page":"15803","DOI":"10.1021\/acsami.5b02831","article-title":"17\u03b2-estradiol-loaded peglyated upconversion nanoparticles as a bone-targeted drug nanocarrier","volume":"7","author":"Hu","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"36","key":"10.1016\/j.actbio.2019.01.060_b1145","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1021\/acs.langmuir.6b02228","article-title":"Bone-targeted mesoporous silica nanocarrier anchored by zoledronate for cancer bone metastasis","volume":"32","author":"Sun","year":"2016","journal-title":"Langmuir"},{"key":"10.1016\/j.actbio.2019.01.060_b1150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2017.08.024","article-title":"Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer","volume":"264","author":"He","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2019.01.060_b1155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2016.04.025","article-title":"Bone-targeted delivery of nanodiamond-based drug carriers conjugated with alendronate for potential osteoporosis treatment","volume":"232","author":"Ryu","year":"2016","journal-title":"J. Control. Release"},{"issue":"21","key":"10.1016\/j.actbio.2019.01.060_b1160","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1016\/j.biomaterials.2014.03.069","article-title":"Synergistic effects of bisphosphonate and calcium phosphate nanoparticles on peri-implant bone responses in osteoporotic rats","volume":"35","author":"Alghamdi","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.01.060_b1165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biomaterials.2017.10.053","article-title":"Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis","volume":"154","author":"Yamashita","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.01.060_b1170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biomaterials.2018.07.046","article-title":"A bone-targeting delivery system carrying osteogenic phytomolecule icaritin prevents osteoporosis in mice","volume":"182","author":"Huang","year":"2018","journal-title":"Biomaterials"},{"issue":"28","key":"10.1016\/j.actbio.2019.01.060_b1175","doi-asserted-by":"crossref","first-page":"23700","DOI":"10.1021\/acsami.8b08606","article-title":"Bone targeted delivery of SDF-1 via alendronate functionalized nanoparticles in guiding stem cell migration","volume":"10","author":"Chen","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b1180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.progpolymsci.2005.09.004","article-title":"Polymer-drug conjugates: progress in polymeric prodrugs","volume":"31","author":"Khandare","year":"2006","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.actbio.2019.01.060_b1185","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b1190","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.actbio.2019.01.060_b1195","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1517\/17425240903044935","article-title":"Nanotechnology controlled drug delivery for treating bone diseases","volume":"6","author":"Yang","year":"2009","journal-title":"Expert Opin. Drug Del."},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b1200","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1021\/bc034090j","article-title":"Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems","volume":"14","author":"Wang","year":"2003","journal-title":"Bioconjug. Chem."},{"issue":"5","key":"10.1016\/j.actbio.2019.01.060_b1205","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1021\/bc0701287","article-title":"A robust and convergent synthesis of dipeptide\u2212DOTAM conjugates as chelators for lanthanide ions: new PARACEST MRI agents","volume":"18","author":"Wojciechowski","year":"2007","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b1210","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/mp800003u","article-title":"Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl)methacrylamide copolymer\u2212alendronate conjugates","volume":"5","author":"Pan","year":"2008","journal-title":"Mol. Pharm."},{"issue":"16","key":"10.1016\/j.actbio.2019.01.060_b1215","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/anie.200805133","article-title":"Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer\u2013alendronate\u2013taxane conjugate","volume":"48","author":"Miller","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b1220","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/mp2001445","article-title":"Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms","volume":"8","author":"Clementi","year":"2011","journal-title":"Mol. Pharm."},{"issue":"19","key":"10.1016\/j.actbio.2019.01.060_b1225","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/j.biomaterials.2011.02.059","article-title":"Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances","volume":"32","author":"Segal","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.01.060_b1230","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2017.07.018","article-title":"Development of PEGylated carboxylic acid-modified polyamidoamine dendrimers as bone-targeting carriers for the treatment of bone diseases","volume":"262","author":"Yamashita","year":"2017","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b1235","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1021\/mp0600539","article-title":"Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers","volume":"3","author":"Wang","year":"2006","journal-title":"Mol. Pharm."},{"issue":"27","key":"10.1016\/j.actbio.2019.01.060_b1240","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1016\/j.biomaterials.2013.05.003","article-title":"Efficiency of high molecular weight backbone degradable HPMA copolymer\u2013prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats","volume":"34","author":"Pan","year":"2013","journal-title":"Biomaterials"},{"issue":"14","key":"10.1016\/j.actbio.2019.01.060_b1245","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/ejoc.200901291","article-title":"Design of bisphosphonate-terminated dendrimers","volume":"2010","author":"Cavero","year":"2010","journal-title":"Eur. J. Org. Chem."},{"issue":"22","key":"10.1016\/j.actbio.2019.01.060_b1250","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1080\/00397910902883660","article-title":"Synthesis of second- and third-generation Asp oligopeptide conjugated dendrimers for bone-targeting drug delivery","volume":"39","author":"Ouyang","year":"2009","journal-title":"Synth. Commun."},{"key":"10.1016\/j.actbio.2019.01.060_b1255","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nm1002","article-title":"Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470","volume":"10","author":"Satchi-Fainaro","year":"2004","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.actbio.2019.01.060_b1260","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b1265","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/mp200083n","article-title":"Antiangiogenic antitumor activity of HPMA copolymer\u2013paclitaxel\u2013alendronate conjugate on breast cancer bone metastasis mouse model","volume":"8","author":"Miller","year":"2011","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.actbio.2019.01.060_b1270","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1021\/bm070121s","article-title":"Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties","volume":"8","author":"Murphy","year":"2007","journal-title":"Biomacromolecules"},{"issue":"8","key":"10.1016\/j.actbio.2019.01.060_b1275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135966","article-title":"Molecular design of bisphosphonate-modified proteins for efficient bone targeting in vivo","volume":"10","author":"Katsumi","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b1280","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bmcl.2007.11.029","article-title":"Chemotherapeutic bone-targeted bisphosphonate prodrugs with hydrolytic mode of activation","volume":"18","author":"Erez","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"16","key":"10.1016\/j.actbio.2019.01.060_b1285","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1021\/acs.jmedchem.6b00951","article-title":"Design, synthesis, and pharmacokinetics of a bone-targeting dual-action prodrug for the treatment of osteoporosis","volume":"60","author":"Xie","year":"2017","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b1290","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1248\/bpb.29.1229","article-title":"Pharmacokinetic advantage of an intranasal preparation of a novel anti-osteoporosis drug, L-Asp-hexapeptide-conjugated estradiol","volume":"29","author":"Yokogawa","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b1295","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/acs.bioconjchem.5b00160","article-title":"Determination of the rat in vivo pharmacokinetic profile of a bone-targeting dual-action pro-drug for treatment of osteoporosis","volume":"26","author":"Chen","year":"2015","journal-title":"Bioconjug. Chem."},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b1300","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.biomaterials.2013.01.059","article-title":"Bifunctional bisphosphonates for delivering PTH (1\u201334) to bone mineral with enhanced bioactivity","volume":"34","author":"Yewle","year":"2013","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.actbio.2019.01.060_b1305","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1021\/jm801007z","article-title":"Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis","volume":"51","author":"Houghton","year":"2008","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.actbio.2019.01.060_b1310","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bmcl.2010.01.006","article-title":"Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis","volume":"20","author":"Tanaka","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b1315","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1021\/acs.jmedchem.6b01615","article-title":"Design, synthesis, and antimicrobial evaluation of a novel bone-targeting bisphosphonate-ciprofloxacin conjugate for the treatment of osteomyelitis biofilms","volume":"60","author":"Sedghizadeh","year":"2017","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b1320","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/AAC.01609-15","article-title":"Novel bone-targeting agent for enhanced delivery of vancomycin to bone","volume":"60","author":"Albayati","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b1325","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/cmdc.200800255","article-title":"Bisphosphonated benzoxazinorifamycin prodrugs for the prevention and treatment of osteomyelitis","volume":"3","author":"Reddy","year":"2008","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.actbio.2019.01.060_b1330","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acs.molpharmaceut.6b00261","article-title":"In vivo bone-targeting of bis(phosphonate)-conjugated double helical RNA monitored by positron emission tomography","volume":"13","author":"Jadhav","year":"2016","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b1335","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/acs.inorgchem.7b03261","article-title":"A Potential bone-targeting hypotoxic platinum(II) complex with an unusual cytostatic mechanism toward osteosarcoma cells","volume":"57","author":"Zhang","year":"2018","journal-title":"Inorg. Chem."},{"issue":"2","key":"10.1016\/j.actbio.2019.01.060_b1340","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/bp990154m","article-title":"Bisphosphonate conjugation to proteins as a means to impart bone affinity","volume":"16","author":"Uludag","year":"2000","journal-title":"Biotechnol. Progress"},{"issue":"3","key":"10.1016\/j.actbio.2019.01.060_b1345","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1021\/bp0200447","article-title":"Targeting systemically administered proteins to bone by bisphosphonate conjugation","volume":"18","author":"Uludag","year":"2002","journal-title":"Biotechnol. Progress"},{"issue":"6","key":"10.1016\/j.actbio.2019.01.060_b1350","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/bp000066y","article-title":"Bone affinity of a bisphosphonate-conjugated protein in vivo","volume":"16","author":"Uludag","year":"2000","journal-title":"Biotechnol. Progress"},{"issue":"20","key":"10.1016\/j.actbio.2019.01.060_b1355","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1016\/j.bmc.2008.09.010","article-title":"Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis","volume":"16","author":"Tanaka","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.actbio.2019.01.060_b1360","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1021\/bc2003132","article-title":"Enhanced affinity bifunctional bisphosphonates for targeted delivery of therapeutic agents to bone","volume":"22","author":"Yewle","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.actbio.2019.01.060_b1365","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biomaterials.2016.11.010","article-title":"Osteotropic peptide-mediated bone targeting for photothermal treatment of bone tumors","volume":"114","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.actbio.2019.01.060_b1370","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1021\/bc500392x","article-title":"Bone-targeted acid-sensitive doxorubicin conjugate micelles as potential osteosarcoma therapeutics","volume":"25","author":"Low","year":"2014","journal-title":"Bioconjug. Chem."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119300820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119300820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:18:26Z","timestamp":1761671906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706119300820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":274,"alternative-id":["S1742706119300820"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2019.01.060","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2019.01.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}